News from bird rock bio, inc.
A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages
16 Mar, 2016, 07:00 GMT Bird Rock Bio's Gerilimzumab, an Anti-IL-6 Antibody, Demonstrates Potential for Affordable Global Access to a Novel Biologic to Treat Rheumatoid Arthritis
- $35 billion is spent annually on therapeutics for rheumatoid arthritis (RA). - RA biologics represent significant healthcare expense, cost up to...